Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer
Jean Bourhis(University Hospital of Lausanne), Alexander Stein(University Cancer Center Hamburg), Jan Paul de Boer(The Netherlands Cancer Institute), Marc Van den Eynde(Cliniques Universitaires Saint-Luc), Kathryn A. Gold(University of California San Diego), Sebastian Stintzing(Charité - Universitätsmedizin Berlin), Jürgen C. Becker(German Cancer Research Center), Michael Moran(Pfizer (Germany)), Andreas Schröeder(Merck (Germany)), Gregory Pennock(Ono Pharmaceutical (United States)), Satu Salmio(Merck (Germany)), Regina Esser(Merck (Germany)), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli")
Cited by 47Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis